Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis/Supply Chain Analysis
6. GLOBAL UVEITIS TREATMENT MARKET, BY TYPE
6.1. Overview
6.2. Anterior Uveitis
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3. Intermediate Uveitis
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4. Posterior Uveitis
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.5. Others
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7. GLOBAL UVEITIS TREATMENT MARKET, BY DRUG CLASS
7.1. Overview
7.2. Corticosteroids Drugs
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.3. Anti-Inflammatory Drugs
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.4. Immunosuppressive Drugs
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.5. Others
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8. GLOBAL UVEITIS TREATMENT MARKET, BY END USER
8.1. Overview
8.2. Hospitals
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.3. Specialty Clinics
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.4. Others
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
9. GLOBAL UVEITIS TREATMENT MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1.1. Overview
10.1.2. Competitive Analysis
10.1.3. Market Share Analysis
10.1.4. Major Growth Strategy in the global uveitis treatment market
10.1.5. Competitive Benchmarking
10.1.6. Leading Player in terms of Number of Developments in global uveitis treatment market
10.1.7. Key Developments & Growth Strategies
10.1.7.1. Product Launch
10.1.7.2. Merger & Acquisition
10.1.7.3. Joint Ventures
10.1.8. Major Players Financial Matrix
10.1.8.1. Sales & Operating Income 2023
10.1.8.2. Major Players R&D Expenditure 2023
11. COMPANY PROFILES
11.1. Allergan PLC
11.1.1. Company Overview
11.1.2. Product Type Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Novartis AG
11.2.1. Company Overview
11.2.2. Product Type Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Bausch Health
11.3.1. Company Overview
11.3.2. Product Type Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. EyePoint Pharmaceuticals, Inc.
11.4.1. Company Overview
11.4.2. Product Type Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. AbbVie Inc.
11.5.1. Company Overview
11.5.2. Product Type Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Horizon Therapeutics PLC
11.6.1. Company Overview
11.6.2. Product Type Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Mylan NV
11.7.1. Company Overview
11.7.2. Product Type Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Alimera Sciences
11.8.1. Company Overview
11.8.2. Product Type Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL UVEITIS TREATMENT MARKET SYNOPSIS, 2023-2032
TABLE 2 GLOBAL UVEITIS TREATMENT MARKET ESTIMATES & FORECAST, 2023-2032(USD MILLION)
TABLE 3 GLOBAL UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 4 GLOBAL UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 5 GLOBAL UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 6 GLOBAL UVEITIS TREATMENT MARKET, BY REGION, 2023-2032(USD MILLION)
TABLE 7 NORTH AMERICA: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 8 NORTH AMERICA: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 9 NORTH AMERICA: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 10 US: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 11 US: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 12 US: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 13 CANADA: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 14 CANADA: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 15 CANADA: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 16 LATIN AMERICA: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 17 LATIN AMERICA: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 18 LATIN AMERICA: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 19 EUROPE: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 20 EUROPE: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 21 EUROPE: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 22 WESTERN EUROPE: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 23 WESTERN EUROPE: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 24 WESTERN EUROPE: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 25 EASTERN EUROPE: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 26 EASTERN EUROPE: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 27 EASTERN EUROPE: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 28 ASIA-PACIFIC: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 29 ASIA-PACIFIC: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 30 ASIA-PACIFIC: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: UVEITIS TREATMENT MARKET, BY TYPE, 2023-2032(USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: UVEITIS TREATMENT MARKET, BY DRUG CLASS, 2023-2032(USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: UVEITIS TREATMENT MARKET, BY END USER, 2023-2032(USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL UVEITIS TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL UVEITIS TREATMENT MARKET
FIGURE 4 GLOBAL UVEITIS TREATMENT MARKET SHARE, BY TYPE, 2023 (%)
FIGURE 5 GLOBAL UVEITIS TREATMENT MARKET SHARE, BY DRUG CLASS, 2023 (%)
FIGURE 6 GLOBAL UVEITIS TREATMENT MARKET SHARE, BY END USER, 2023 (%)
FIGURE 7 GLOBAL UVEITIS TREATMENT MARKET SHARE, BY REGION, 2023 (%)
FIGURE 7 AMERICAS: UVEITIS TREATMENT MARKET SHARE BY REGION, 2023 (%)
FIGURE 8 NORTH AMERICA: UVEITIS TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 9 EUROPE: UVEITIS TREATMENT MARKET SHARE, BY REGION, 2023 (%)
FIGURE 10 WESTERN EUROPE: UVEITIS TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 11 ASIA-PACIFIC: UVEITIS TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 12 MIDDLE EAST & AFRICA: UVEITIS TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 13 GLOBAL UVEITIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 ALLERGAN PLC: KEY FINANCIALS
FIGURE 15 ALLERGAN PLC: SEGMENTAL REVENUE
FIGURE 16 ALLERGAN PLC: REGIONAL REVENUE
FIGURE 17 NOVARTIS AG: KEY FINANCIALS
FIGURE 18 NOVARTIS AG: SEGMENTAL REVENUE
FIGURE 19 NOVARTIS AG: REGIONAL REVENUE
FIGURE 20 BAUSCH HEALTH: KEY FINANCIALS
FIGURE 21 BAUSCH HEALTH: SEGMENTAL REVENUE
FIGURE 22 BAUSCH HEALTH: REGIONAL REVENUE
FIGURE 23 EYEPOINT PHARMACEUTICALS, INC.: KEY FINANCIALS
FIGURE 24 EYEPOINT PHARMACEUTICALS, INC.: SEGMENTAL REVENUE
FIGURE 25 EYEPOINT PHARMACEUTICALS, INC.: REGIONAL REVENUE
FIGURE 26 ABBVIE INC.: KEY FINANCIALS
FIGURE 27 ABBVIE INC.: SEGMENTAL REVENUE
FIGURE 28 ABBVIE INC.: REGIONAL REVENUE
FIGURE 29 HORIZON THERAPEUTICS PLC: KEY FINANCIALS
FIGURE 30 HORIZON THERAPEUTICS PLC: SEGMENTAL REVENUE
FIGURE 31 HORIZON THERAPEUTICS PLC: REGIONAL REVENUE
FIGURE 32 ALIMERA SCIENCES: KEY FINANCIALS
FIGURE 33 ALIMERA SCIENCES: SEGMENTAL REVENUE
FIGURE 34 ALIMERA SCIENCES: REGIONAL REVENUE